GeneDx Holdings Corp.

Historical 13F Holders

Symbol
WGS
CUSIP
81663L200
All holders as of
Q2 2026
Type
Equity
Class
COM CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 81663L200 since 12/18/2024, newest first.

Filer % of Class Filed
Goldman Sachs Group Inc 13G
5.8% 8/11/2026
Event 6/30/2026
ARK Investment Management LLC 13G/A Amendment 1
5.3% 8/7/2026
Event 7/31/2026
BlackRock, Inc. 13G 5.5% 7/28/2026
Event 6/30/2026
CMLS Holdings LLC 13D/A Amendment 12
17.9% 5/22/2026
Event 5/20/2026
CMLS Holdings LLC 13D/A Amendment 11
17.9% 5/15/2026
Event 5/14/2026
CMLS Holdings LLC 13D/A Amendment 10
16.7% 5/11/2026
Event 5/7/2026
William Blair Investment Management, LLC 13G/A Amendment 1 4.3% 11/12/2025
Event 9/30/2025
CMLS Holdings LLC 13D/A Amendment 9
12.5% 8/26/2025
Event 8/22/2025
Summit Partners Public Asset Management, LLC 13G/A Amendment 1
3.0% 8/14/2025
Event 6/30/2025
FMR LLC 13G/A Amendment 1
0.6% 8/6/2025
Event 6/30/2025
William Blair Investment Management, LLC 13G 5.7% 7/30/2025
Event 6/30/2025
FMR LLC 13G
10.0% 5/12/2025
Event 3/31/2025
Goldman Sachs Group Inc 13G/A Amendment 1
3.9% 5/9/2025
Event 3/31/2025
CMLS Holdings LLC 13D/A Amendment 8
14.2% 5/7/2025
Event 5/5/2025
Summit Partners Public Asset Management, LLC 13G
5.2% 2/12/2025
Event 2/5/2025
Goldman Sachs Group Inc 13G
5.2% 2/5/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 13 746 k $53.9 M
2026 Q2 242 33.4 M $2.21 B
2026 Q1 258 31.3 M $2.01 B
2025 Q4 316 31.2 M $4.05 B
2025 Q3 297 30.1 M $3.25 B
2025 Q2 263 31.5 M $2.91 B
2025 Q1 250 28.4 M $2.52 B
2024 Q4 214 23.5 M $1.81 B
2024 Q3 149 18.9 M $802 M
2024 Q2 96 16.5 M $432 M
2024 Q1 65 15.5 M $141 M
2023 Q4 55 14.9 M $41.0 M
2023 Q3 60 13.9 M $50.8 M
2023 Q2 66 14.0 M $83.2 M
2023 Q1 2 26.7 M $9.63 M